Super-resolution microscopy reveals dense glycoprotein clusters in plasma membrane during Ebola infection, suggesting new therapeutic potential.
The glycoprotein (GP) of Ebola virus plays a central role in the viral entry into host cells. The detailed study of Ebola glycoprotein in the cellular system is unknown, mainly due to the resolution limit (~λ/2) of optical fluorescence microscopes. To overcome this, we propose to use single-molecule localization microscopy (SMLM), which enables the study of the role of glycoproteins at both the single-molecule and ensemble levels. Accordingly, a photoactivable recombinant probe Dendra2-EboVGlyc is developed by linking Ebola glycoprotein with Dendra2. The transient expression of photoactivable recombinant protein in NIH3T3 cells indicated the dominant presence of glycoprotein in the plasma membrane with regions of densely packed glycoproteins. Super-resolution single-molecule imaging gives direct proof of glycoprotein clusters in the plasma membrane. The corresponding single-molecule analysis using DBSCAN clustering algorithm reveals a dense packing of glycoprotein with an estimated average density of 5345 mol/μm 2 compared to the density in other regions of the membrane. The number of glycoproteins is estimated to be as high as 642 molecules per cluster and clusters spread area of ≈ 0.1219 μm 2 after 48 hrs post-transfection. Noting that glycoprotein is involved in cellular attachment, endosomal entry, and membrane fusion, the formation of glycoprotein clusters in the membrane is significant in the progression of Ebola pathogenesis. A drug capable of dispersing the glycoproteins clusters could be of therapeutic potential to lessen the intensity of infection and to slow down the disease progression.
No takes yet. Share an insight, caveat, or question.
Mondal et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: